{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T02:43:21Z","timestamp":1790822601561,"version":"4.1.0"},"reference-count":34,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Thyroid\u00ae"],"published-print":{"date-parts":[[2018,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Thyroid storm (TS) is life threatening. In the mid-2000s, its incidence was poorly defined, peer-reviewed diagnostic criteria were not available, and management and treatment did not seem to be verified based upon evidence and latest advances in medicine.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>First, diagnostic criteria were developed based on 99 patients in the literature and seven patients in this study. Then, initial and follow-up surveys were conducted from 2004 through 2008, targeting all hospitals in Japan to obtain and verify information on patients who met diagnostic criteria for TS. Based on these data, the diagnostic criteria were revised, and management and treatment guidelines were created.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The incidence of TS in hospitalized patients in Japan was estimated to be 0.20 per 100,000 per year and 0.22% of all thyrotoxic patients. The mortality rate was 10.7%. Multiple organ failure was the most common cause of death, followed by congestive heart failure, respiratory failure, and arrhythmia. In the final diagnostic criteria for TS, the definition of jaundice as serum bilirubin concentration &gt;3\u2009mg\/dL was added. Based upon nationwide surveys and the latest information, guidelines for the management and treatment for TS were extensively revised and algorithms were developed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>TS remains a life-threatening disorder, with &gt;10% mortality in Japan. New peer-reviewed diagnostic criteria for TS are presented and its clinical features, prognosis, and incidence are clarified based on nationwide surveys. Furthermore, this information helped to establish detailed guidelines for the management and treatment of TS. A prospective prognostic study to validate the guidelines is eagerly anticipated.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1089\/thy.2017.0243","type":"journal-article","created":{"date-parts":[[2017,10,5]],"date-time":"2017-10-05T16:30:42Z","timestamp":1507221042000},"page":"32-40","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":110,"title":["Thyroid Storm: A Japanese Perspective"],"prefix":"10.1177","volume":"28","author":[{"given":"Takashi","family":"Akamizu","sequence":"first","affiliation":[{"name":"Wakayama Medical University","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2018,1,1]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM192808091990601"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-193204000-00008"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197011052831911"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-7125(16)30090-6"},{"key":"e_1_3_3_6_2","first-page":"492","volume-title":"Werner & Ingbar's The Thyroid. A Fundamental and Clinical Text","author":"Cooper DS","year":"2012","unstructured":"Cooper DS. 2012. Treatment of thyrotoxicosis. In: Braverman L, , Cooper DS (eds) Werner & Ingbar's The Thyroid. A Fundamental and Clinical Text. Tenth edition. Lippincott Williams & Wilkins, Philadelphia, PA, pp 492\u2013516."},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1022933918182"},{"key":"e_1_3_3_8_2","first-page":"69","article-title":"Management of thyrotoxic crisis","volume":"9","author":"Migneco A","year":"2005","unstructured":"Migneco A, , Ojetti V, , Testa A, , De Lorenzo A, , Gentiloni Silveri N. 2005. Management of thyrotoxic crisis. Eur Rev Med Pharmacol Sci, 9:69\u201374.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"e_1_3_3_9_2","first-page":"651","volume-title":"Werner & Ingbar's The Thyroid","author":"Wartofsky L","year":"2005","unstructured":"Wartofsky L. 2005. Thyrotoxic storm. In: Braverman L, , Utiger R (eds) Werner & Ingbar's The Thyroid. Ninth edition. Williams & Wilkins, Philadelphia, PA, pp 651\u2013657."},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8529(18)30165-8"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2011.0334"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.EJ16-0336"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/cen.12949"},{"key":"e_1_3_3_14_2","first-page":"81","article-title":"Thyroid storm","volume":"6","author":"Dillmann WH","year":"1997","unstructured":"Dillmann WH. 1997. Thyroid storm. Curr Ther Endocrinol Metab, 6:81\u201385.","journal-title":"Curr Ther Endocrinol Metab"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(15)00225-9"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1210\/endo-125-1-76"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1677\/joe.1.06354"},{"key":"e_1_3_3_18_2","first-page":"91","article-title":"Acute physiology and chronic health evaluation (APACHE II) and Medicare reimbursement","author":"Wagner DP","year":"1984","unstructured":"Wagner DP, , Draper EA. 1984. Acute physiology and chronic health evaluation (APACHE II) and Medicare reimbursement. Health Care Financ Rev, Suppl:91\u2013105.","journal-title":"Health Care Financ Rev"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01709751"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/s001340050863"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0950-351X(05)80332-5"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-7125(16)30478-3"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2012.2207.ed1"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecl.2006.09.008"},{"key":"e_1_3_3_25_2","first-page":"393","volume-title":"Williams Textbook of Endocrinology","author":"Davies T","year":"2015","unstructured":"Davies T, , Laurberg P, , Bahn RS. 2015. Thyroid storm. In: Melmed S, , Polonsky K, , Larsen P, , Kronenberg H (eds) Williams Textbook of Endocrinology. Thirteenth edition. Elsevier Saunders, Philadelphia, PA, pp 393\u2013395."},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2016.0229"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2012.2211.com"},{"key":"e_1_3_3_28_2","first-page":"10","volume-title":"Endocrine News","author":"Horvath K","year":"2014","unstructured":"Horvath K. 2014. Cover story: gathering storm. Endocrine News. Endocrine Society, Washington, DC, pp 10\u201313."},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI107744"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI25083"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-2135"},{"key":"e_1_3_3_32_2","unstructured":"Japan Thyroid Association 2011 Selection of Antithyroid Agents. Therapeutic Guideline for Graves' Disease 2011. Nankodo Inc. Tokyo Japan pp 24\u201330."},{"key":"e_1_3_3_33_2","unstructured":"Vydro L Joglekar S Sheh S Yau H Naing S. 2015. Choice of antithyroid drugs and the outcome of patients with thyroid storm. 15th International Thyroid Congress Orlando FL."},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2009.03745.x"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2014.0084"}],"container-title":["Thyroid\u00ae"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/thy.2017.0243","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/thy.2017.0243","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/thy.2017.0243","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T22:03:30Z","timestamp":1777586610000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/thy.2017.0243"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["10.1089\/thy.2017.0243"],"URL":"https:\/\/doi.org\/10.1089\/thy.2017.0243","relation":{},"ISSN":["1050-7256","1557-9077"],"issn-type":[{"value":"1050-7256","type":"print"},{"value":"1557-9077","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1]]}}}